Bafna Pharmaceuticals Limited (BAFNAPH.NS) NSE

176.33

+8.39(+5.00%)

Updated at September 26 03:26PM

Currency In INR

Valuation

Market Cap1.77B
Enterprise Value2.02B
P/E Ratio50.56
PEG Ratio0.51
Price/Sales Ratio2.83
Price/Book Ratio4.93
Enterprise/Revenue3
Enterprise/EBITDA27.5

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.06
Operating Margin0.07

Management Effectiveness

Return On Assets0.05
Return On Equity0.1

Income Statement

Revenue1.46B
Revenue/Share62.11
Gross Profit168.77M
EBITDA117.74M
Net Income41.53M
Diluted EPS1.76

Balance Sheet

Total Cash34.33M
Total Cash/Share1.45
Total Debt281.99M
Total Debt/Equity0.33
Current Ratio1.63
Book Value Per Share36.59

Price History

52-Week Change107.47
52-Week High176.33
52-Week Low69
Moving Average 50 Days106.01
Moving Average 200 Days85.15

Statistics

Average Volume20,813
Shares Outstanding23.66M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateAugust 26, 2019